Reproductive · PANCE / PANRE

Ectopic Pregnancy

Implantation outside the uterine cavity — most commonly tubal; life-threatening hemorrhage if ruptured.

Also known as: ectopic pregnancy, tubal pregnancy, ruptured ectopic, heterotopic pregnancy

Overview

Implantation of a fertilized ovum outside the uterine cavity; ~95% occur in the fallopian tube (ampulla most common). Non-tubal sites include cornual/interstitial, cervical, ovarian, abdominal, and cesarean scar pregnancies.

Epidemiology

~1-2% of all pregnancies in the US. Leading cause of maternal mortality in the first trimester (~4% of pregnancy-related deaths). Higher incidence with ART and PID.

Try two board-style Ectopic Pregnancy questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1ReproductiveMedium
A 16-year-old girl presents with severe lower abdominal pain and vaginal bleeding. Last menstrual period was 7 weeks ago. β-human chorionic gonadotropin (β-hCG) is 4,200 mIU/mL. Transvaginal ultrasound shows no intrauterine pregnancy and free pelvic fluid. BP is 82/54 mmHg and HR is 128/min. Which of the following is the most appropriate immediate management?
  • ABlood transfusion with inpatient observation
  • BEmergent surgical exploration
  • CDiagnostic laparoscopy after stabilization
  • DSingle-dose intramuscular methotrexate
Reveal answer & full explanation
Correct answer: B — Emergent surgical exploration
  • ABlood transfusion with inpatient observation
  • BEmergent surgical exploration
  • CDiagnostic laparoscopy after stabilization
  • DSingle-dose intramuscular methotrexate

Why emergent surgical exploration is correct

  • This is a ruptured ectopic pregnancy with hemodynamic instability (BP 82/54 mmHg, HR 128/min), which is a surgical emergency.
  • Free pelvic fluid on ultrasound indicates hemoperitoneum from rupture.
  • No intrauterine pregnancy on transvaginal ultrasound (TVUS) with β-human chorionic gonadotropin (β-hCG) of 4,200 mIU/mL — above the discriminatory zone of 1,500–2,500 mIU/mL — raises high suspicion for ectopic pregnancy.
  • Management: immediate IV access, type and crossmatch, fluid resuscitation, and emergent operating room for salpingectomy.

Why the others are wrong

  • A) Blood transfusion with inpatient observation — Transfusion supports the circulation but provides no source control; hemorrhage from the ruptured tube continues until it is operatively removed, so resuscitation must accompany surgery rather than substitute for it.
  • C) Diagnostic laparoscopy after stabilization — Diagnostic laparoscopy is the appropriate surgical approach when stable; however, with frank hemodynamic instability and suspected rupture, emergent exploration (which may require laparotomy) takes priority over a staged approach.
  • D) Single-dose intramuscular methotrexate — Contraindicated in this setting; methotrexate requires hemodynamic stability and no active bleeding.
Question 2ReproductiveMedium
A 26-year-old woman presents with sudden unilateral pelvic pain, vaginal spotting, and 7 weeks of amenorrhea. Beta-hCG is 2,800 mIU/mL. Transvaginal ultrasound shows no intrauterine pregnancy. She is hemodynamically stable. What is the management?
  • ARepeat beta-hCG in 48 hours
  • BDilation and curettage
  • CVaginal misoprostol
  • DMethotrexate 50 mg/m2 IM
Reveal answer & full explanation
Correct answer: D — Methotrexate 50 mg/m2 IM
  • ARepeat beta-hCG in 48 hours
  • BDilation and curettage
  • CVaginal misoprostol
  • DMethotrexate 50 mg/m2 IM

Why Methotrexate 50 mg/m2 IM is correct

  • Ectopic pregnancy is diagnosed when hCG is above the discriminatory zone (1,500-2,000 mIU/mL) with no intrauterine pregnancy (IUP) on transvaginal ultrasound (TVUS); hCG here is 2,800 mIU/mL
  • Methotrexate is appropriate when criteria are met: hemodynamic stability, no rupture, hCG below 5,000 mIU/mL, ectopic mass below 3.5 cm, no fetal cardiac activity, and normal renal/hepatic/CBC labs; this patient is stable with an hCG of 2,800, and the remaining criteria are confirmed before dosing

Why the others are wrong

  • Repeat beta-hCG in 48 hours — waiting with hCG above the discriminatory zone and no IUP on TVUS risks rupture
  • Dilation and curettage — does not treat a tubal ectopic pregnancy
  • Vaginal misoprostol — a uterotonic that expels an intrauterine gestation; it has no effect on trophoblast implanted in the tube and leaves the ectopic in place to rupture

Additional high-yield points

  • Risk factors for ectopic pregnancy: prior pelvic inflammatory disease (PID), tubal surgery, intrauterine device (IUD), prior ectopic
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Ectopic Pregnancy outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Prior ectopic pregnancy (10x risk)
  • Prior tubal surgery (sterilization, reanastomosis)
  • Tubal pathology (PID, salpingitis, hydrosalpinx)
  • Pregnancy with IUD in place
  • Assisted reproductive technology
  • Endometriosis
  • Smoking
  • Diethylstilbestrol exposure (historical)
  • Infertility, advanced maternal age

Pathophysiology

Damaged or dysfunctional fallopian tubes impair ovum transport, leading to implantation in tubal mucosa. As trophoblast invades the thin tubal wall, hemorrhage occurs, leading to tubal distension, abortion, or rupture with intraperitoneal hemorrhage. β-hCG production is typically lower than in intrauterine pregnancy and rises more slowly.

Clinical presentation

Symptoms

  • Amenorrhea (missed period)
  • Unilateral pelvic or abdominal pain
  • Vaginal bleeding (often light)
  • Shoulder tip pain (referred from diaphragmatic blood)
  • Dizziness, syncope (hemorrhage)
  • Some are asymptomatic and detected on early pregnancy ultrasound

Signs / physical exam

  • Adnexal tenderness, ± palpable adnexal mass
  • Cervical motion tenderness
  • Peritoneal signs if ruptured
  • Hypotension, tachycardia (hemorrhagic shock)
  • Mild uterine enlargement (decidualized endometrium)

Classic findings

Reproductive-age woman with amenorrhea, unilateral pelvic pain, vaginal bleeding, positive pregnancy test, and no intrauterine pregnancy on TVUS.

Differential diagnosis

  • Intrauterine pregnancy (early) — β-hCG, ultrasound for gestational sac
  • Threatened or completed spontaneous abortion — Bleeding with intrauterine pregnancy; falling β-hCG
  • Pelvic inflammatory disease — Fever, cervical motion tenderness, no pregnancy
  • Ovarian torsion — Sudden severe unilateral pain, nausea/vomiting; Doppler ultrasound
  • Ruptured ovarian cyst — Sudden pain; ultrasound free fluid
  • Appendicitis — RLQ pain, anorexia; CT
  • Gestational trophoblastic disease — Markedly elevated β-hCG, 'snowstorm' on ultrasound, hyperemesis
  • Heterotopic pregnancy — Concurrent intrauterine and ectopic — rare except with ART (~1:100 vs 1:30,000 spontaneous)

Diagnostic workup

Diagnostic criteria

Pregnancy of unknown location: positive β-hCG without IUP or extrauterine findings on TVUS — requires serial β-hCG and possibly D&C to distinguish failed IUP from ectopic. Ectopic confirmed by visualization of extrauterine pregnancy or by absence of chorionic villi on D&C with persistent or rising β-hCG.

Labs

  • Quantitative serum β-hCG — discriminatory zone ~1500-3500 mIU/mL above which intrauterine pregnancy should be visible on TVUS
  • Serial β-hCG every 48 hours: normal IUP doubles in 48 h (rises ≥35%); abnormal rise/plateau/fall suggests nonviable IUP or ectopic
  • CBC (anemia from bleeding), type and screen, Rh status
  • Quantitative β-hCG after definitive treatment to confirm resolution (<5 mIU/mL)

Imaging

  • Transvaginal ultrasound — primary imaging; look for intrauterine gestational sac (with yolk sac or embryo), adnexal mass, free fluid in pelvis
  • Doppler may show 'ring of fire' (vascular ectopic)
  • Definitive: extrauterine gestational sac with yolk sac/embryo or extrauterine cardiac activity
  • Pseudogestational sac (collapsed fluid in endometrial cavity) can mimic IUP — careful evaluation

Diagnostic algorithm

flowchart TD
  A[Positive β-hCG +<br/>pain/bleeding] --> B[Hemodynamic status]
  B -->|Unstable / rupture| C[Emergent laparoscopic<br/>salpingectomy<br/>blood products]
  B -->|Stable| D[TVUS + quantitative β-hCG]
  D --> E{IUP visible?}
  E -->|Yes| F[Intrauterine pregnancy<br/>± heterotopic if ART/risk]
  E -->|Ectopic seen| G[Treat ectopic]
  E -->|Indeterminate| H{β-hCG vs<br/>discriminatory zone}
  H -->|Above + no IUP| I[Likely ectopic or<br/>nonviable IUP — repeat US,<br/>± D&C, treat as ectopic if confirmed]
  H -->|Below| J[Repeat β-hCG in 48 h]
  J --> K{Rise ≥35%?}
  K -->|Yes| L[Likely IUP — repeat US<br/>when above zone]
  K -->|No| M[Nonviable: ectopic or<br/>failed IUP — definitive workup]
  G --> N{MTX candidate?}
  N -->|Yes| O[Methotrexate IM<br/>+ serial β-hCG]
  N -->|No| P[Laparoscopic surgery]
Algorithm for suspected ectopic pregnancy.

Treatment

First-line

  • Hemodynamically unstable, ruptured, or large ectopic: emergent surgery (laparoscopic salpingectomy preferred over salpingostomy)
  • Hemodynamically stable, candidate criteria met: methotrexate (intramuscular)
  • Anti-D immunoglobulin (RhoGAM) for Rh-negative women
  • All require post-treatment β-hCG monitoring until <5 mIU/mL

Methotrexate (medical management)

  • Single-dose protocol: methotrexate 50 mg/m² IM; check β-hCG day 4 and day 7; expect ≥15% decline from day 4 to day 7; weekly until <5 mIU/mL
  • Two-dose and multi-dose protocols for larger or higher β-hCG ectopics
  • Criteria: hemodynamically stable, no rupture, β-hCG ideally <5000 mIU/mL, ectopic size <3.5-4 cm, no fetal cardiac activity, no significant free fluid, reliable follow-up
  • Contraindications: hemodynamic instability, hepatic/renal/hematologic disease, immunodeficiency, peptic ulcer, breastfeeding, intrauterine pregnancy, inability to follow up

Surgical management

  • Laparoscopic salpingectomy — preferred for ruptured, large, or recurrent ectopic; complete removal of affected tube
  • Laparoscopic salpingostomy — fertility-preserving, but ~10% require additional treatment for persistent trophoblast; check post-op β-hCG weekly
  • Laparotomy if hemodynamically unstable or extensive adhesions

Expectant management

  • Selected very-early ectopics with low and falling β-hCG, no symptoms, reliable follow-up
  • Serial β-hCG until <5 mIU/mL

Complications

  • Hemorrhage and hemorrhagic shock — most common cause of first-trimester maternal mortality
  • Tubal rupture
  • Loss of fallopian tube → reduced future fertility
  • Recurrent ectopic (10% risk)
  • Methotrexate side effects: bone marrow suppression, hepatotoxicity, mucositis, pneumonitis
  • Persistent trophoblast after salpingostomy

PANCE pearls

  • Always check β-hCG in any reproductive-age woman with abdominal pain or abnormal bleeding.
  • Heterotopic pregnancy is rare spontaneously (1:30,000) but more common with ART (~1:100) — ALWAYS evaluate adnexa even when IUP is identified.
  • Methotrexate is contraindicated with concurrent IUP, hepatic/renal disease, hematologic disorders, immunodeficiency, peptic ulcer, breastfeeding, or unreliable follow-up.
  • Beware of pseudogestational sac (collapsed fluid in endometrial cavity); look for true yolk sac or embryo to confirm IUP.
  • Rh-negative women with any pregnancy bleeding require RhoGAM (50 mcg if <12 weeks; 300 mcg if ≥12 weeks).
  • After methotrexate, advise avoiding alcohol, NSAIDs, folic acid supplements, sexual intercourse, sun exposure, and pregnancy for at least 3 months.

References

  • ACOG PB 193 — ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy
  • ASRM 2013 — Medical Treatment of Ectopic Pregnancy: A Committee Opinion (Fertil Steril 2013)
  • Stovall Protocol — Single-dose Methotrexate: An Expanded Clinical Trial (Stovall and Ling, Am J Obstet Gynecol 1993)

Practice Reproductive questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.